Global Blood Therapeutics, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenues
Product sales, net
Costs and operating expenses:
Cost of sales
Research and development
Selling, general and administrative
Total costs and operating expenses
Loss from operations
Interest income, net
Other income (expense):
Interest income
Interest expense
Other expenses, net
Loss before income taxes
Provision for income taxes
Total other income (expense), net
Net loss
Other comprehensive loss:
Net unrealized gain (loss) on marketable securities, net of tax
Cumulative translation adjustment
Total other comprehensive income (expense), net
Comprehensive loss
Basic and diluted net loss per common share
Weighted-average number of shares used in computing basic and diluted net loss per common share

Comments